Tender glossary
Centralised procedure
Definition
The EU route in which the European Medicines Agency assesses a medicine and the European Commission grants one authorisation valid in every member state.
In practice
It is mandatory for many biologics and innovative medicines and optional for some generics.
Example
A biosimilar receives one EU-wide authorisation, valid in every member state at once. Launches and first tenders then follow country by country, often over several years.
Why it matters for suppliers
For tender planning, a central authorisation is only the start. Each country then decides on pricing and reimbursement, and buyers launch their own tenders on their own calendars, so competition from a newly authorised product arrives market by market.
Related terms
See how this plays out in your own tenders
RGS tracks tenders and awards across Europe and applies these rules automatically.